Europe—not US—first to authorize Moderna's combo mRNA flu-COVID vaccine
Amid RFK Jr.'s anti-vaccine agenda, Moderna withdrew its FDA application last year.
Signal weather
Stable
The story has moved beyond the first headline and now acts as a reliable context anchor.
Moderna's mRNA-based combination vaccine against both flu and COVID-19 has gotten the green light in Europe—but it continues to be shelved in the US, where it was developed. This week, the European Commission authorized Moderna to market the vaccine, mRNA-1083 or mCOMBRIAX, making it the world's first authorized combination shot for the two respiratory viruses. The decision follows a positive review in February from a key European Medicines Agency's committee, which paved the way for the approval. Moderna CEO Stéphane Bancel welcomed the news. "By combining protection against two significant respiratory viruses in a single dose, our vaccine aims to simplify immunization for adults, particularly those at high risk," Bancel said in a press release. "mCOMBRIAX offers an important new option for Europeans, while also aiming to strengthen the resilience of healthcare systems across Europe."Read full article Comments
Stay on the signal
Follow Europe—not US—first to authorize Moderna's combo mRNA flu-COVID vaccine
Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.
Story map
Understand this topic fast
A quick entry into the story: why it matters now, who is involved, and where to go next for context.
Why it matters now
Topic constellation
Open the live map for this story
See which entities, story threads, sources, and follow-up articles shape this story right now.
Click nodes to continue
Story threads
Story timeline
Continue with this story
A short sequence of events and follow-up stories to understand the arc quickly.
How reliable this looks
Signal and trust for Ars Technica
This source works at a rapid pace: 100% of recent stories land in the hot window, and 0% carry visible search signal.
Reliability
92
Freshness
100
Sources in storyline
2
Related articles
More stories that share tags, source, or category context.
Satellite images reveal Putin is preparing for war with Europe
Comments
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
PeopleSoft 0-day affecting hundreds of organizations steals gigabytes of data
Vulnerability in the Oracle-owned PeopleSoft software is about as critical as they come.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Controversial FISA spying law expires tonight. The spying will continue.
Section 702 of FISA to expire tonight, but certification lasts until March 2027.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Here's what Jeff Bezos' new startup Prometheus will do
It isn't the only startup tackling physical AI, but it's one of the best-funded.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
More from Ars Technica
Fresh reporting and follow-up coverage from the same newsroom.
PeopleSoft 0-day affecting hundreds of organizations steals gigabytes of data
Vulnerability in the Oracle-owned PeopleSoft software is about as critical as they come.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Controversial FISA spying law expires tonight. The spying will continue.
Section 702 of FISA to expire tonight, but certification lasts until March 2027.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Here's what Jeff Bezos' new startup Prometheus will do
It isn't the only startup tackling physical AI, but it's one of the best-funded.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Have politics finally come for the National Academies of Science?
A pending report on climate attribution may be setting the stage for conflict.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.